International Clinical Trial: Mouse Nerve Growth Factor as an Adjuvant Therapy for Retinal Vein Occlusion

Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134624) titled 'Mouse Nerve Growth Factor as an Adjuvant Therapy for Retinal Vein Occlusion' on Oct. 17.

Study Type: Observational study

Study Design: Non randomized control

Primary Sponsor: Tianjin Medical University Eye Hospital

Condition: retinal vein occlusion

Intervention: mouse nerve growth factor group (anti-VEGF drugs+mouse nerve growth factor):None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-31

Target Sample Size: mouse nerve growth factor group (anti-VEGF drugs+mouse nerve growth factor):20;no mouse nerve growth factor group (anti-VEGF drugs):20;

Countries of Recruitm...